PharmaVOICE - 
January 2015
Purchase Issue

In Every Issue
Letter from the Editor
Cancer — Impacts Us All In 2014, there were an [...]
By

Taren Grom, Editor

UpFront
The Amgen Foundation Expands Amgen Scholars Program The Amgen Scholars [...]
By

Denise Myshko

Innovator’s Corner
From Smart Pills to Digital Medicines Markus Christen, Ph.D., Senior [...]
By

Markus Christen, Ph.D., Senior VP, Global Development, Proteus Digital Health

The Network
Using Digital Across the Spectrum to Improve Care Trending Now: [...]
By

Taren Grom, Editor

Tools of the Trade
Pharma Companies Help Shape Accenture Life Sciences Cloud for R&D [...]
By

Denise Myshko

Pharma Trax
Sales, marketing, And R&D?Trends affecting the healthcare industry Pharma Companies [...]
By

Denise Myshko

On the Calendar
Coming Attractions During the 2015 ePharma Summit, Conference Chairman Paul [...]
By

Heather Hummel

Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool [...]
By

PharmaVOICE Staff

Last Word
Guiding Regulators About Patient Safety Volker Knappertz, M.D., VP and [...]
By

Volker Knappertz, M.D., VP and Head of Global Clinical Development for MS at Teva Pharmaceuticals

On The Cover

Detangling Oncology
Oncology is expected to be the biggest therapeutic class by 2017. In this first article in an ongoing series addressing various aspects involved with oncology, experts examine the market drivers, research highlights, and marketing, sales, and payer considerations of this market. In 2014, there were an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer [...]
By

Denise Myshko, Robin Robinson, Taren Grom, Editor

Features

Where Have All The Sales Reps Gone?
The death of the pharma sales rep has been greatly exaggerated, however, the role of the sales rep is headed for big changes. Healthcare providers are choosing multiple channels to receive their information on pharma products, which could lead to the assumption that pharma sales reps could soon be a thing of the past. However, [...]
By

Robin Robinson

Using Consumer Data In R&D
Consumer and personal health data will play a larger role in clinical research in the future. More and more data relevant to health are being captured by consumers and patients through patient diaries, monitoring devices, and health and fitness tracking diaries, and apps. Patient and consumer data, experts say, can provide better measures of everyday [...]
By

Denise Myshko

Track And Trace: Preparing For DSCSA Implementation
The first deadline of the 10-year DSCSA Implementation Plan takes effect this month, and experts say many drug manufacturers are not ready. The Drug Supply Chain Security Act (DSCSA) Implementation Plan regulation, which began phasing in on Jan. 1, 2015, provides a national policy for combating counterfeiting, theft, and diversion in the U.S. pharmaceutical supply [...]
By

Robin Robinson

South Korea
Proven R&D capabilities, a strong regulatory system, government support, and a wealth of talent are among the factors that draw pharma companies to South Korea. South Korea, or the Republic of Korea, is an industrialized nation with a strong standing on the world stage. It was the first Asian country to host the G20 summit [...]
By

Kim Ribbink

C-Suite: Clinical Services
We asked C-suite executives throughout the clinical services ecosystem to provide their insights on what the biggest opportunities for innovation are, what the biggest barriers are, and identify a recent innovation that is improving the process. Dr. Martine Dehlinger-Kremer Global VP, Medical and Regulatory Affairs SynteractHCR Opportunities: As we all are aware, developing new drugs [...]
By

Taren Grom, Editor

SHOWCASE FEATURE: Social Media: A Social Revolution
As pharmaceutical companies continue to dabble in social media, patients and consumers are not waiting, and are in fact, driving health-related conversations in a variety of ways and across a variety of media, most importantly digital. A recent study found that one-quarter of the world’s population uses social media. This means that 1,730,000,000 people are [...]
By

Taren Grom, Editor

Making Better Connections With Context
Our involvement in social media requires thoughtful planning; predetermined and approved frameworks;  rules of engagement, content workflows, and efficient approval workflows;  monitoring technologies; legal guidelines; and integrated QA processes. My job, probably yours too, is to connect HCPs and patients with health solutions. It might be a new innovation in insulin delivery for PWT2D, or [...]
By

Ben Currie, VP, Digital Solutions, GA Communication

Making Social Count: How Mobile and Data Help Social Media Reach Their Potential
For years, pharmaceutical marketers have talked about moving “beyond the pill.”  We know our work needs to provide patients with tools and services to help manage and improve their health, in concert with — or even instead of — our prescription brands. We’ve exhorted each other to not be satisfied with a great detail aid, [...]
By

Sarah Morgan, Content Strategist, Intouch Solutions

Social Media Has Revolutionized The Healthcare Industry
The marketing function of the pharmaceutical industry needs to begin focusing on changing its thinking around social media, to more of an -engagement-oriented model and less around advertising and promotion. Social should be viewed as an integral part of the overall marketing mix and not silo’d or being the domain of corporate communications. It was [...]
By

Ritesh Patel, Executive VP, Chief Digital Officer of Ogilvy CommonHealth in New Jersey and Ogilvy Healthworld in New York

FEEDBACK